Cargando…
Manufacture of a Stable Lyophilized Formulation of the Live Attenuated Pertussis Vaccine BPZE1
Current pertussis vaccines protect against disease, but not against colonization by and transmission of Bordetella pertussis, whereas natural infection protects against both. The live attenuated vaccine BPZE1 was developed to mimic immunogenicity of natural infection without causing disease, and in...
Autores principales: | Thalen, Marcel, Debrie, Anne-Sophie, Coutte, Loic, Raze, Dominique, Solovay, Ken, Rubin, Keith, Mielcarek, Nathalie, Locht, Camille |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565209/ https://www.ncbi.nlm.nih.gov/pubmed/32933132 http://dx.doi.org/10.3390/vaccines8030523 |
Ejemplares similares
-
Live Attenuated Pertussis Vaccine BPZE1 Protects Baboons Against Bordetella pertussis Disease and Infection
por: Locht, Camille, et al.
Publicado: (2017) -
Immunogenicity of Live Attenuated B. pertussis BPZE1 Producing the Universal Influenza Vaccine Candidate M2e
por: Kammoun, Hana, et al.
Publicado: (2013) -
A Phase I Clinical Study of a Live Attenuated Bordetella pertussis Vaccine - BPZE1; A Single Centre, Double-Blind, Placebo-Controlled, Dose-Escalating Study of BPZE1 Given Intranasally to Healthy Adult Male Volunteers
por: Thorstensson, Rigmor, et al.
Publicado: (2014) -
Live Attenuated B. pertussis as a Single-Dose Nasal Vaccine against Whooping Cough
por: Mielcarek, Nathalie, et al.
Publicado: (2006) -
Suppression of mucosal Th17 memory responses by acellular pertussis vaccines enhances nasal Bordetella pertussis carriage
por: Dubois, Violaine, et al.
Publicado: (2021)